Department of Hepatopancreatobiliary Surgery, West China Hospital, No. 37, Guoxue Alley, Chengdu 610041, Sichuan, China.
Int J Hematol. 2013 May;97(5):610-6. doi: 10.1007/s12185-013-1328-6. Epub 2013 Apr 17.
The purpose of this study was to investigate the long-term effects of laparoscopic splenectomy (LS) for patients with chronic immune thrombocytopenia (ITP), and to identify predictive factors for promising hematological outcomes. We retrospectively analyzed the clinical records and follow-up data in patients who underwent LS for chronic ITP from November 2005 to August 2012. The related parameters were assessed by univariate and multivariate logistic regression analyses. The curve of life table was drawn to clarify the long-term response rate. Of the 92 included patients, 49 (53.3 %) patients achieved a complete response, 21 patients (22.8 %) a partial response, and the remaining 22 (23.9 %) showed no response to LS. Eleven patients relapsed within 1 year after LS, especially within 3 months (n = 7), while three patients relapsed 17, 26, and 28 months after LS, respectively. Long-term specific complications after LS were not observed. Platelet counts on postoperative month 3 (POM 3) is a significant independent predictor of long-term favorable hematological outcomes (P < 0.001). Based on our study, we conclude that LS is associated with promising long-term response for patients with chronic ITP, and platelet counts on POM 3 could be used as a predictor of long-term hematological outcome.
本研究旨在探讨腹腔镜脾切除术(LS)治疗慢性免疫性血小板减少症(ITP)患者的长期疗效,并确定预测有利血液学结局的因素。我们回顾性分析了 2005 年 11 月至 2012 年 8 月期间接受 LS 治疗的慢性 ITP 患者的临床记录和随访数据。通过单因素和多因素逻辑回归分析评估相关参数。绘制寿命表曲线以阐明长期缓解率。在 92 例纳入的患者中,49 例(53.3%)患者达到完全缓解,21 例(22.8%)患者达到部分缓解,其余 22 例(23.9%)患者对 LS 无反应。11 例患者在 LS 后 1 年内复发,尤其是在 3 个月内(n=7),而 3 例患者分别在 LS 后 17、26 和 28 个月复发。LS 后未观察到长期特定并发症。LS 后 3 个月(POM3)的血小板计数是长期良好血液学结局的显著独立预测因素(P<0.001)。基于我们的研究,我们得出结论,LS 与慢性 ITP 患者的长期良好缓解相关,POM3 的血小板计数可作为长期血液学结局的预测因素。